세계의 휴대형 심장 모니터링 기기 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

The global market for Ambulatory Cardiac Monitoring Devices was estimated to be worth US$ 1054 million in 2024 and is forecast to a readjusted size of US$ 1447 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Ambulatory Cardiac Monitoring Devices cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Ambulatory Cardiac Monitoring Devices refer to wearable or implantable devices designed to continuously or intermittently monitor the heart's electrophysiological activity outside fixed medical environments, often over extended periods. Their purpose is to detect cardiac anomalies such as arrhythmias, atrial fibrillation, bradycardia, and tachycardia that are not easily captured during brief or static examinations. These devices typically include electrode or lead systems, signal transmission or storage units, data analysis modules (including remote or cloud infrastructure), and may integrate mobile communication, wireless technologies, and AI-driven analytics to enhance detection sensitivity and user convenience. Use cases span in-hospital monitoring, outpatient/ambulatory care, home healthcare, and remote health management, making them essential tools in cardiovascular disease management and prevention of adverse cardiac events.In 2024, global Ambulatory Cardiac Monitoring Device production reached approximately 1171 k units, with an average global market price of around US$ 900 perunit.

With accelerating global population ageing and rising incidence of chronic cardiovascular diseases (such as atrial fibrillation, arrhythmias, and hypertension-induced cardiac stress), there is a growing demand for preventive monitoring and early diagnosis. Governments in many countries have made chronic disease management, public health policy, and healthcare innovation-including remote medicine, digital health, localized medical device innovation-core priorities. Policies and subsidies nurture remote cardiac monitoring adoption; national health plans such as "Healthy China 2030" in China, U.S./EU medical reform programs emphasize early screening and remote care. Technologically, advances in wireless transmission, continuous monitoring (wearable, multi-lead, MEMS electrodes, biosensors), implantable or patch-type designs, and AI/ML algorithms for signal processing and prediction have significantly improved accuracy, comfort, portability, and user experience. Acceptance of wearable, remote, home monitoring devices is rapidly rising. Manufacturing and supply chain, benefitting from economies of scale and widespread electronics/materials supply, are seeing cost declines, improving margins, and attracting investment from venture capital, private equity, and established med-tech firms.Despite great potential, the industry faces several significant challenges. Firstly, regulatory and compliance barriers are high: different countries/regions require stringent safety, clinical validation, and certification procedures, which take time and cost, especially burdening small-to-medium enterprises. Secondly, privacy & data security risks: continuous monitoring involves sensitive physiological data transmitted wirelessly or stored in the cloud; encryption, compliance (e.g. GDPR, HIPAA, national laws) must be rigorous, and breaches can damage trust and incur legal liability. Third, user acceptability and comfort: wearable/patch devices may cause skin irritation, discomfort, limited battery life, motion/sweat/environment noise interference; implantable devices involve surgical risk and higher cost. Fourth, the high cost of high-end innovative technologies and R&D: if reimbursement or insurance systems do not cover these devices, adoption will be constrained. Also, in low-/middle-income countries, limited healthcare infrastructure and lower purchasing power restrict market penetration.Downstream demand is trending toward greater diversity, personalization, and integration. Home care and at-home medical monitoring are major growth areas, particularly after the COVID-19 pandemic normalized remote healthcare; patients and families prefer portable, user-friendly, connected devices. Hospitals and diagnostic centers increasingly demand "real-time monitoring + data-analytics + remote reporting", with seamless integration into hospital information systems (HIS), electronic medical records (EMR), and telehealth platforms, to reduce manual review, improve accuracy, speed of response. Another trend is the business model "hardware + software + services": beyond the device itself, value-added services (data interpretation, report generation, arrhythmia prediction / early warnings) are becoming competitive differentiators. Growing insurance / reimbursement coverage also amplifies demand strength. Among younger populations, high acceptance of wearable health devices drives demand for preventive ECG monitoring, heart rate variability monitoring during exercise, etc.

This report aims to provide a comprehensive presentation of the global market for Ambulatory Cardiac Monitoring Devices, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Ambulatory Cardiac Monitoring Devices by region & country, by Type, and by Application.

The Ambulatory Cardiac Monitoring Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ambulatory Cardiac Monitoring Devices.

Market Segmentation

By Company

• Medtronic
• Abbott
• GE Healthcare
• Philips Healthcare
• Hill-Rom
• Medicomp
• Schiller
• Spacelabs Healthcare
• Applied Cardiac Systems
• iRhythm
• Bio Telemetry
• Medicalgorithmics

Segment by Type

• Holter Monitor
• Event Monitor
• Mobile Cardiac Telemetry
• Others

Segment by Application

• Hospitals
• Ambulatory Care Centers
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Ambulatory Cardiac Monitoring Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Ambulatory Cardiac Monitoring Devices in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Ambulatory Cardiac Monitoring Devices in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Ambulatory Cardiac Monitoring Devices Product Introduction
• 1.2 Global Ambulatory Cardiac Monitoring Devices Market Size Forecast
  • 1.2.1 Global Ambulatory Cardiac Monitoring Devices Sales Value (2020-2031)
  • 1.2.2 Global Ambulatory Cardiac Monitoring Devices Sales Volume (2020-2031)
  • 1.2.3 Global Ambulatory Cardiac Monitoring Devices Sales Price (2020-2031)
• 1.3 Ambulatory Cardiac Monitoring Devices Market Trends & Drivers
  • 1.3.1 Ambulatory Cardiac Monitoring Devices Industry Trends
  • 1.3.2 Ambulatory Cardiac Monitoring Devices Market Drivers & Opportunity
  • 1.3.3 Ambulatory Cardiac Monitoring Devices Market Challenges
  • 1.3.4 Ambulatory Cardiac Monitoring Devices Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Ambulatory Cardiac Monitoring Devices Players Revenue Ranking (2024)
• 2.2 Global Ambulatory Cardiac Monitoring Devices Revenue by Company (2020-2025)
• 2.3 Global Ambulatory Cardiac Monitoring Devices Players Sales Volume Ranking (2024)
• 2.4 Global Ambulatory Cardiac Monitoring Devices Sales Volume by Company Players (2020-2025)
• 2.5 Global Ambulatory Cardiac Monitoring Devices Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Ambulatory Cardiac Monitoring Devices Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Ambulatory Cardiac Monitoring Devices Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Ambulatory Cardiac Monitoring Devices
• 2.9 Ambulatory Cardiac Monitoring Devices Market Competitive Analysis
  • 2.9.1 Ambulatory Cardiac Monitoring Devices Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Ambulatory Cardiac Monitoring Devices Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ambulatory Cardiac Monitoring Devices as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Holter Monitor
  • 3.1.2 Event Monitor
  • 3.1.3 Mobile Cardiac Telemetry
  • 3.1.4 Others
• 3.2 Global Ambulatory Cardiac Monitoring Devices Sales Value by Type
  • 3.2.1 Global Ambulatory Cardiac Monitoring Devices Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Ambulatory Cardiac Monitoring Devices Sales Value, by Type (2020-2031)
  • 3.2.3 Global Ambulatory Cardiac Monitoring Devices Sales Value, by Type (%) (2020-2031)
• 3.3 Global Ambulatory Cardiac Monitoring Devices Sales Volume by Type
  • 3.3.1 Global Ambulatory Cardiac Monitoring Devices Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Ambulatory Cardiac Monitoring Devices Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Ambulatory Cardiac Monitoring Devices Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Ambulatory Cardiac Monitoring Devices Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Hospitals
  • 4.1.2 Ambulatory Care Centers
  • 4.1.3 Others
• 4.2 Global Ambulatory Cardiac Monitoring Devices Sales Value by Application
  • 4.2.1 Global Ambulatory Cardiac Monitoring Devices Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Ambulatory Cardiac Monitoring Devices Sales Value, by Application (2020-2031)
  • 4.2.3 Global Ambulatory Cardiac Monitoring Devices Sales Value, by Application (%) (2020-2031)
• 4.3 Global Ambulatory Cardiac Monitoring Devices Sales Volume by Application
  • 4.3.1 Global Ambulatory Cardiac Monitoring Devices Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Ambulatory Cardiac Monitoring Devices Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Ambulatory Cardiac Monitoring Devices Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Ambulatory Cardiac Monitoring Devices Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Ambulatory Cardiac Monitoring Devices Sales Value by Region
  • 5.1.1 Global Ambulatory Cardiac Monitoring Devices Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Ambulatory Cardiac Monitoring Devices Sales Value by Region (2020-2025)
  • 5.1.3 Global Ambulatory Cardiac Monitoring Devices Sales Value by Region (2026-2031)
  • 5.1.4 Global Ambulatory Cardiac Monitoring Devices Sales Value by Region (%), (2020-2031)
• 5.2 Global Ambulatory Cardiac Monitoring Devices Sales Volume by Region
  • 5.2.1 Global Ambulatory Cardiac Monitoring Devices Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Ambulatory Cardiac Monitoring Devices Sales Volume by Region (2020-2025)
  • 5.2.3 Global Ambulatory Cardiac Monitoring Devices Sales Volume by Region (2026-2031)
  • 5.2.4 Global Ambulatory Cardiac Monitoring Devices Sales Volume by Region (%), (2020-2031)
• 5.3 Global Ambulatory Cardiac Monitoring Devices Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Ambulatory Cardiac Monitoring Devices Sales Value, 2020-2031
  • 5.4.2 North America Ambulatory Cardiac Monitoring Devices Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Ambulatory Cardiac Monitoring Devices Sales Value, 2020-2031
  • 5.5.2 Europe Ambulatory Cardiac Monitoring Devices Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Ambulatory Cardiac Monitoring Devices Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Ambulatory Cardiac Monitoring Devices Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Ambulatory Cardiac Monitoring Devices Sales Value, 2020-2031
  • 5.7.2 South America Ambulatory Cardiac Monitoring Devices Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Ambulatory Cardiac Monitoring Devices Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Ambulatory Cardiac Monitoring Devices Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Ambulatory Cardiac Monitoring Devices Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Ambulatory Cardiac Monitoring Devices Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Ambulatory Cardiac Monitoring Devices Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Ambulatory Cardiac Monitoring Devices Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Ambulatory Cardiac Monitoring Devices Sales Value, 2020-2031
  • 6.3.2 United States Ambulatory Cardiac Monitoring Devices Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Ambulatory Cardiac Monitoring Devices Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Ambulatory Cardiac Monitoring Devices Sales Value, 2020-2031
  • 6.4.2 Europe Ambulatory Cardiac Monitoring Devices Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Ambulatory Cardiac Monitoring Devices Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Ambulatory Cardiac Monitoring Devices Sales Value, 2020-2031
  • 6.5.2 China Ambulatory Cardiac Monitoring Devices Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Ambulatory Cardiac Monitoring Devices Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Ambulatory Cardiac Monitoring Devices Sales Value, 2020-2031
  • 6.6.2 Japan Ambulatory Cardiac Monitoring Devices Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Ambulatory Cardiac Monitoring Devices Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Ambulatory Cardiac Monitoring Devices Sales Value, 2020-2031
  • 6.7.2 South Korea Ambulatory Cardiac Monitoring Devices Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Ambulatory Cardiac Monitoring Devices Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Ambulatory Cardiac Monitoring Devices Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Ambulatory Cardiac Monitoring Devices Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Ambulatory Cardiac Monitoring Devices Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Ambulatory Cardiac Monitoring Devices Sales Value, 2020-2031
  • 6.9.2 India Ambulatory Cardiac Monitoring Devices Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Ambulatory Cardiac Monitoring Devices Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Medtronic
  • 7.1.1 Medtronic Company Information
  • 7.1.2 Medtronic Introduction and Business Overview
  • 7.1.3 Medtronic Ambulatory Cardiac Monitoring Devices Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Medtronic Ambulatory Cardiac Monitoring Devices Product Offerings
  • 7.1.5 Medtronic Recent Development
• 7.2 Abbott
  • 7.2.1 Abbott Company Information
  • 7.2.2 Abbott Introduction and Business Overview
  • 7.2.3 Abbott Ambulatory Cardiac Monitoring Devices Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Abbott Ambulatory Cardiac Monitoring Devices Product Offerings
  • 7.2.5 Abbott Recent Development
• 7.3 GE Healthcare
  • 7.3.1 GE Healthcare Company Information
  • 7.3.2 GE Healthcare Introduction and Business Overview
  • 7.3.3 GE Healthcare Ambulatory Cardiac Monitoring Devices Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 GE Healthcare Ambulatory Cardiac Monitoring Devices Product Offerings
  • 7.3.5 GE Healthcare Recent Development
• 7.4 Philips Healthcare
  • 7.4.1 Philips Healthcare Company Information
  • 7.4.2 Philips Healthcare Introduction and Business Overview
  • 7.4.3 Philips Healthcare Ambulatory Cardiac Monitoring Devices Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Philips Healthcare Ambulatory Cardiac Monitoring Devices Product Offerings
  • 7.4.5 Philips Healthcare Recent Development
• 7.5 Hill-Rom
  • 7.5.1 Hill-Rom Company Information
  • 7.5.2 Hill-Rom Introduction and Business Overview
  • 7.5.3 Hill-Rom Ambulatory Cardiac Monitoring Devices Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Hill-Rom Ambulatory Cardiac Monitoring Devices Product Offerings
  • 7.5.5 Hill-Rom Recent Development
• 7.6 Medicomp
  • 7.6.1 Medicomp Company Information
  • 7.6.2 Medicomp Introduction and Business Overview
  • 7.6.3 Medicomp Ambulatory Cardiac Monitoring Devices Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Medicomp Ambulatory Cardiac Monitoring Devices Product Offerings
  • 7.6.5 Medicomp Recent Development
• 7.7 Schiller
  • 7.7.1 Schiller Company Information
  • 7.7.2 Schiller Introduction and Business Overview
  • 7.7.3 Schiller Ambulatory Cardiac Monitoring Devices Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Schiller Ambulatory Cardiac Monitoring Devices Product Offerings
  • 7.7.5 Schiller Recent Development
• 7.8 Spacelabs Healthcare
  • 7.8.1 Spacelabs Healthcare Company Information
  • 7.8.2 Spacelabs Healthcare Introduction and Business Overview
  • 7.8.3 Spacelabs Healthcare Ambulatory Cardiac Monitoring Devices Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 Spacelabs Healthcare Ambulatory Cardiac Monitoring Devices Product Offerings
  • 7.8.5 Spacelabs Healthcare Recent Development
• 7.9 Applied Cardiac Systems
  • 7.9.1 Applied Cardiac Systems Company Information
  • 7.9.2 Applied Cardiac Systems Introduction and Business Overview
  • 7.9.3 Applied Cardiac Systems Ambulatory Cardiac Monitoring Devices Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Applied Cardiac Systems Ambulatory Cardiac Monitoring Devices Product Offerings
  • 7.9.5 Applied Cardiac Systems Recent Development
• 7.10 iRhythm
  • 7.10.1 iRhythm Company Information
  • 7.10.2 iRhythm Introduction and Business Overview
  • 7.10.3 iRhythm Ambulatory Cardiac Monitoring Devices Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 iRhythm Ambulatory Cardiac Monitoring Devices Product Offerings
  • 7.10.5 iRhythm Recent Development
• 7.11 Bio Telemetry
  • 7.11.1 Bio Telemetry Company Information
  • 7.11.2 Bio Telemetry Introduction and Business Overview
  • 7.11.3 Bio Telemetry Ambulatory Cardiac Monitoring Devices Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.11.4 Bio Telemetry Ambulatory Cardiac Monitoring Devices Product Offerings
  • 7.11.5 Bio Telemetry Recent Development
• 7.12 Medicalgorithmics
  • 7.12.1 Medicalgorithmics Company Information
  • 7.12.2 Medicalgorithmics Introduction and Business Overview
  • 7.12.3 Medicalgorithmics Ambulatory Cardiac Monitoring Devices Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.12.4 Medicalgorithmics Ambulatory Cardiac Monitoring Devices Product Offerings
  • 7.12.5 Medicalgorithmics Recent Development

8 Industry Chain Analysis

• 8.1 Ambulatory Cardiac Monitoring Devices Industrial Chain
• 8.2 Ambulatory Cardiac Monitoring Devices Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Ambulatory Cardiac Monitoring Devices Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Ambulatory Cardiac Monitoring Devices Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer